BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12595948)

  • 1. An evaluation of the effect of NAS-181, a new selective 5-HT(1B) receptor antagonist, on extracellular 5-HT levels in rat frontal cortex.
    de Groote L; Klompmakers AA; Olivier B; Westenberg HG
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):89-94. PubMed ID: 12595948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of extracellular serotonin levels in the effect of 5-HT1B receptor blockade.
    de Groote L; Klompmakers AA; Olivier B; Westenberg HG
    Psychopharmacology (Berl); 2003 May; 167(2):153-8. PubMed ID: 12644890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice.
    de Groote L; Olivier B; Westenberg HG
    Psychopharmacology (Berl); 2002 Aug; 162(4):419-24. PubMed ID: 12172696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN; Greenslade RG; Cooper J
    Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.
    De Groote L; Olivier B; Westenberg HG
    Eur J Pharmacol; 2002 Mar; 439(1-3):93-100. PubMed ID: 11937097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
    Dawson LA; Nguyen HQ
    Neuropharmacology; 2000 Apr; 39(6):1044-52. PubMed ID: 10727715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated administration of the 5-HT(1B) receptor antagonist SB-224289 blocks the desensitisation of 5-HT(1B) autoreceptors induced by fluoxetine in rat frontal cortex.
    Shalom G; Gur E; Van de Kar LD; Newman ME
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):84-90. PubMed ID: 15309378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of chronic selective serotonin reuptake inhibitor treatment on serotonin 1B receptor sensitivity and HPA axis activity.
    Jongsma ME; Bosker FJ; Cremers TI; Westerink BH; den Boer JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):738-44. PubMed ID: 15961207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the 5-HT1B receptor antagonist NAS-181 on extracellular levels of acetylcholine, glutamate and GABA in the frontal cortex and ventral hippocampus of awake rats: a microdialysis study.
    Hu XJ; Wang FH; Stenfors C; Ogren SO; Kehr J
    Eur Neuropsychopharmacol; 2007 Sep; 17(9):580-6. PubMed ID: 17234388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
    Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced 5-HT metabolism and synthesis rate by the new selective r5-HT1B receptor antagonist, NAS-181 in the rat brain.
    Stenfors C; Yu H; Ross SB
    Neuropharmacology; 2000 Feb; 39(4):553-60. PubMed ID: 10728876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors.
    Hervás I; Artigas F
    Eur J Pharmacol; 1998 Sep; 358(1):9-18. PubMed ID: 9809863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of 5-HT(1B/1D) receptors in the modulation of 5-hydroxytryptamine levels in the frontal cortex of the conscious guinea pig.
    Roberts C; Price GW; Jones BJ
    Eur J Pharmacol; 1997 May; 326(1):23-30. PubMed ID: 9178651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the 5-HT1D receptor antagonist GR127935 on extracellular levels of 5-HT in the guinea-pig frontal cortex as measured by microdialysis.
    Skingle M; Sleight AJ; Feniuk W
    Neuropharmacology; 1995 Apr; 34(4):377-82. PubMed ID: 7566468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex.
    Malagié I; Trillat AC; Bourin M; Jacquot C; Hen R; Gardier AM
    J Neurochem; 2001 Feb; 76(3):865-71. PubMed ID: 11158258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New selective and potent 5-HT(1B/1D) antagonists: chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides.
    Liao Y; Böttcher H; Harting J; Greiner H; van Amsterdam C; Cremers T; Sundell S; März J; Rautenberg W; Wikström H
    J Med Chem; 2000 Feb; 43(3):517-25. PubMed ID: 10669578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of 5-HT1B/1D receptor antagonists in dorsal and median raphe innervated brain regions.
    Roberts C; Belenguer A; Middlemiss DN; Routledge C
    Eur J Pharmacol; 1998 Apr; 346(2-3):175-80. PubMed ID: 9652357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935.
    Gobert A; Rivet JM; Cistarelli L; Millan MJ
    J Neurochem; 1997 Mar; 68(3):1159-63. PubMed ID: 9048762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.